Statistics display that about half of individuals with early stage illnesses have an aggressive type of CLL leading to early death. Experts hope that EGCG can stabilize CLL for early stage sufferers or perhaps enhance the performance of treatment when combined with other therapies. The research has shifted to the second phase of clinical testing in a follow-up trial – – already fully enrolled – – involving roughly the same quantity of patients. All will have the highest dosage administered from the prior trial. Related StoriesPotential new medication target for severe myeloid leukemiaAnalysis of high-throughput sequencing data reveals fresh genes associated with chronic lymphocytic leukemiaYK-4-279 compound functions against some forms of leukemia: StudyThese scientific studies are the latest guidelines in a multiyear bench-to-bedside task that began with exams of the green tea extract on malignancy cells in the laboratory of Mayo hematologist Neil Kay, M.D., a co-author upon this article.‘Trouble in Toyland:’ 14 potentially dangerous toys U.S. Public Curiosity Analysis Group releases its 27th annual ‘Trouble in Toyland’ report to spotlight dangers for kids Parents should also check the minimum age group requirements for toys before providing them with to children. Many plaything stores have tube testing gadgets that allow parents to observe if a gadget is too little for a kid. Beware that older children might give youngsters toys they can choke on. In case of a crisis, parents should know first-help for choking and CPR.